| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |